Catalent to Expand Kentucky Controlled-release Drug Manufacturing Facility

Catalent Pharma Solutions, a drug delivery technology and advanced supply solutions company, has announced a major expansion of its controlled release drug manufacturing facility in Winchester, Kentucky.

The company is to invest nearly $35 million to expand the 100,000 square-foot facility by almost 80,000 square feet, and will add as many as 90 new employees at the expanded site.

Construction will commence on June 12, 2013 with a ceremony led by Kentucky Governor Steve Beshear and Catalent President and CEO John Chiminski.

Catalent expects to complete the expansion by October 2014, and will welcome customers to tour the facility at that time.

The Winchester expansion comes on the heels of several significant investments Catalent has made in advanced delivery technologies globally. Mr. Chiminski notes, "As with Winchester, Catalent continues to invest to meet the most critical needs of the industry, including recently announced inhalation facility expansion in North Carolina, our recently completed biologics expansion in Wisconsin, and our two new ventures in China, which will focus on softgel technologies and clinical trial supplies."

 

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.